Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Gan & Lee Pharmaceuticals.

Market Cap 32.19B 4.76B 4.11B 3.78B 3.56B 6.68B 450B 6.74B 44.77B 17.43B 221B 17.88B 17.49B 763B P/E 2026 *
23.3x
P/E 2027 * 19.9x
Enterprise Value 28.98B 4.29B 3.7B 3.4B 3.2B 6.02B 405B 6.07B 40.3B 15.69B 199B 16.09B 15.75B 687B EV / Sales 2026 *
6.13x
EV / Sales 2027 * 5.03x
Free-Float
57.73%
Yield 2026 *
0.44%
Yield 2027 * 0.52%
1 day-1.37%
1 week-3.67%
Current month+3.44%
1 month-4.35%
3 months-13.50%
6 months-19.04%
Current year-20.55%
1 week 53.36
Extreme 53.36
56.65
1 month 51.51
Extreme 51.51
57.32
Current year 51.51
Extreme 51.51
74.47
1 year 51.51
Extreme 51.51
82.25
3 years 32.1
Extreme 32.1
82.25
5 years 30.53
Extreme 30.53
117
10 years 30.53
Extreme 30.53
204.41
Manager TitleAgeSince
Chief Executive Officer 46 29/05/2025
Director of Finance/CFO 44 08/03/2026
Chief Tech/Sci/R&D Officer - 08/03/2026
Director TitleAgeSince
Chairman 78 16/06/1998
Director/Board Member 49 31/12/2009
Director/Board Member 44 14/09/2015
Date Insider Type Main position Quantity % Market Cap.
19/08/25Sell

Chief Financial Officer

20,000 0.0038%
12/08/25Sell

Director

27,500 0.0052%
05/06/24Buy

Director

150,000 0.0282%
Change 5-day change 1-year change 3-year change Capi.($)
-1.37%-3.67%-0.28%+43.56% 4.76B
-1.11%+1.04%+19.47%-22.36% 61.85B
-0.12%-6.94%+62.55%+199.52% 55.69B
+2.78%+37.00%+37.00%+37.00% 41.88B
+1.21%+0.79%-55.33%-62.00% 36.15B
+1.56%+2.28%+56.98%-33.22% 29.33B
+11.55%+34.38%+141.88%-51.99% 24.52B
-0.76%-6.07%+43.86%+56.56% 19.78B
+1.74%+4.39%-3.12%+113.90% 16.61B
+0.48%+0.82%+56.96%+102.75% 16.2B
Average +0.57%+3.89%+36.00%+38.37% 30.68B
Weighted average by Cap. +0.58%+3.52%+36.26%+38.04%

Financials

2026 *2027 *
Net sales 4.73B 699M 603M 555M 522M 981M 66B 989M 6.57B 2.56B 32.39B 2.62B 2.57B 112B 5.53B 819M 706M 649M 611M 1.15B 77.26B 1.16B 7.7B 3B 37.92B 3.07B 3.01B 131B
Net income 1.39B 206M 178M 163M 154M 289M 19.44B 291M 1.94B 754M 9.54B 773M 757M 33.01B 1.63B 241M 208M 191M 180M 338M 22.73B 341M 2.26B 881M 11.15B 904M 885M 38.59B
Net Debt -3.21B -475M -410M -377M -355M -666M -44.83B -672M -4.47B -1.74B -22B -1.78B -1.74B -76.12B -4.36B -645M -557M -512M -482M -905M -60.91B -913M -6.07B -2.36B -29.89B -2.42B -2.37B -103B
Logo Gan & Lee Pharmaceuticals.
Gan & Lee Pharmaceuticals is a China-based company primarily engaged in the research, development, production, and sales of insulin analogue active pharmaceutical ingredients and injectable formulations. The Company’s main products include glargine insulin injection, lispro insulin injection, mixed protamine zinc lispro insulin injection, aspart insulin injection, aspart 30 insulin injection, and mixed protamine human insulin injection. The Company is also engaged in the provision of medical device products, including reusable pen insulin injectors, non-reusable pen injectors, disposable injection pen needles, and disposable insulin pen needles. The Company distributes its products within the domestic market and to overseas markets.
Employees
5,309
Date Price Change Volume
17/06/26 54.08 ¥ -1.37% 5,882,819
16/06/26 54.83 ¥ -2.96% 5,951,581
15/06/26 56.50 ¥ +1.58% 5,313,310
12/06/26 55.62 ¥ -0.34% 5,799,124
11/06/26 55.81 ¥ -0.59% 4,906,419
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
54.08CNY
Average target price
72.50CNY
Spread / Average Target
+34.06%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 603087 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!